Last reviewed · How we verify

NCT04809168

Neuropathic Spinal Pain in Ankylosing Spondylitis

Active, enrolled Last updated 21 May 2025
What this trial tests

trial testing Questionnaires and inventories in Ankylosing Spondylitis in 292 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
6 April 2021
Primary endpoint
2 November 2024
2 December 2025

Quick facts

Lead sponsorBozyaka Training and Research Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment292
Start date6 April 2021
Primary completion2 November 2024
Estimated completion2 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bozyaka Training and Research Hospital

Who can join

Adults 18 to 70, any sex, with Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate prevalence of neuropathic spinal pain in AS patients and it's impact on sleep quality. Moreover effects of neuropathic pain on quality of life and fatigue will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ankylosing Spondylitis

Currently open trials in the same condition.

Other Bozyaka Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04809168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing